Article
B-cell phenotype and IgD-CD27- memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis.
PloS one - 1 Jan 2017
Moura Rita A, Quaresma Cláudia, Vieira Ana R, Gonçalves Maria J, Polido-Pereira Joaquim, Romão Vasco C, Martins Nádia, Canhão Helena, Fonseca João E
Abstract excerpt
BACKGROUND: The use of TNF-inhibitors and/or the IL-6 receptor antagonist, tocilizumab, in rheumatoid arthritis (RA) have pleiotropic effects that also involve circulating B-cells. The main goal of this study was to assess the effect of TNF-inhibitors and tocilizumab on B-cell phenotype and gene expression in RA. METHODS: Blood samples were collected from untreated early RA (ERA) patients, established RA patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
